Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India
· Delayed Price · Currency is INR 1,441.00
+23.60 (1.67%)
May 14, 2025, 3:30 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 407.19 billion as of May 14, 2025. Its market cap has increased by 34.74% in one year.
Market Cap
407.19B
Enterprise Value
406.79B
Revenue
139.61B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,441.00
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 407.19B, an increase of 35,329.08%. That is a compound annual growth rate of 27.77%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,186.36B |
| Divi's Laboratories | 1,599.58B |
| Cipla | 1,195.31B |
| Mankind Pharma | 993.57B |
| Apollo Hospitals Enterprise | 966.52B |
| Zydus Lifesciences | 884.13B |
| Aurobindo Pharma | 676.29B |
| Alkem Laboratories | 591.43B |